Cancer

New hope for the 20 percent of kids who don’t respond to standard cancer treatment

A new drug combination being trialled in a groundbreaking CHU Sainte-Justine/University of Montreal study is giving hope for survival, healing and improved quality of life to the 20% of children who do not respond to standard cancer treatments. Known as DEC-GEN, it’s the world’s first study involving children with solid tumors or recurrent or refractory leukemia. It was designed at the CHU Sainte-Justine Research Centre by principal investigators Dr. Noël Raynal and Dr. Henrique Bittencourt, both professors at the University of Montreal, and aims to evaluate the effectiveness in children of a combination of two drugs which are already used individually in the treatment of cancers. This drug combination therapy developed at the Institut national de la recherche scientifique (INRS).

Read more 0 Comments
Psychology & Psychiatry

Sexuality orients stress reactivity

Gay and bisexual men and heterosexual women have lower stress reactivity compared to heterosexual men. This is the surprising conclusion of a doctoral study undertaken by Robert-Paul Juster of the Institut universitaire en santé mental de Montréal’s Centre for Studies on Human Stress, under the supervision of Sonia Lupien, a professor at the University of Montreal’s Department of Psychiatry.

Read more 0 Comments